Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

An Investigation of a Working Memory Training program in Brain Tumor Survivors with Cognitive Impairments

You are here

Principal Investigator: Amanda Sacks-Zimmerman, PhD

The purpose of this study is to determine the cognitive functioning of individuals after standard treatment of low-grade gliomas. Additionally, to determine if cognitive functioning is improved with a computerized working memory training program. This research is being done because there is a growing interest in cancer survivorship; including enhancing quality of life after cancer treatment. Cognitive functioning is a large part of quality of life after cancer treatment. Therefore, determining the impact of a computerized working memory training program on cognitive functioning is a significant part of the cancer survivorship mission.

Have you had a treatment for Low Grade Glioma (brain tumor)?

Treatment for Low-Grade Glioma can include surgery, radiation, and chemotherapy. Some patients may experience changes in attention, focus, organization, or memory after these treatments.

Why is this study being done?

In this study we are looking to measure the effects of a computerized working memory training program on things like attention and memory and how much this program might help people who are having trouble with these cognitive problems; specifically after they have had medical treatment for low grade brain tumor.

What does this study involve?

  • An initial visit to Weill Cornell Medical College for testing of attention, memory, and other cognitive functions and study orientation (maximum 2 hours)
  • 5 weeks of computer based training that can be completed in the comfort of your home for 1 hour per day.
  • A second visit at the end of 5 weeks of working memory training computer program for re-testing (maximum 1.5 hours)
  • A follow-up visit 3 months after completing the working memory training computer program (maximum 1.5 hours)

What does this study cost?

There is no cost to participating in this study to you or your insurance company. You will receive a Metrocard as compensation for the study visit.

How do I participate?

If you are interested in participating, please call Dr. Amanda Sacks-Zimmerman and the research team at (212) 746-3356.